Likeness Rx

01 / Select the relevant page

This profile concerns Likeness Rx's GLP-1 offer. Its other service pages should not be treated as evidence about this particular prescription route. On October 5, 2026, the GLP-1 page advertised monthly compounded semaglutide at $139 and tirzepatide at $199, with lower monthly equivalents on longer terms.

02 / Distinguish clinical and commercial instructions

The clinician's plan explains the proposed treatment. The purchase terms explain payment, renewal and cancellation. A change to one does not automatically resolve the other. Ask the service how clinical changes are handled during a prepaid term and retain the written answer relevant to the plan you select.

03 / Read the conditions

The page describes automatic renewal for the selected term and an early first-refill charge. It also describes a refund condition for a person who is not prescribed treatment. That condition should not be broadened into an unrestricted refund promise. A lower monthly equivalent can involve a larger total commitment, so compare the complete obligation.

04 / Verify the preparation

Compounded GLP-1 medicines are not FDA-approved. Ask which pharmacy will dispense the actual order and obtain the corresponding product information. A pharmacy associated with Likeness's skincare service is not necessarily the GLP-1 dispensing pharmacy. Where instructions are unclear, the prescriber or pharmacist should resolve them before use.

Likeness is our third publisher-selected promotional placement, with possible compensation from links. We have not assessed the service's patient outcomes, fulfillment or response quality. The briefing separates the medication, the clinical responsibility and the contract so that a reader can ask specific questions rather than treating a single advertisement as a complete care plan.

Return to the access comparison →